Literature DB >> 26090370

Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works.

Suleyman Cetinkunar1, Hasan Erdem1, Recep Aktimur1, Selim Sozen1.   

Abstract

Obesity and diabetes is a co-pandemic and a major health concern that is expanding. It has many psychosocial and economic consequences due to morbidity and mortality of this disease combination. The pathophysiology of obesity and related diabetes is complex and multifactorial. One arm of this disease process is the genetic susceptibility. Other arm is dependent on the intricate neuro-humoral factors that converge in the central nerve system. Gut hormones and the adipose tissue derived factors plays an important role in this delicate network. Bariatric surgery provides the only durable option for treatment of obesity and furthermore it provides a remission in the concomitant diseases that accompany obesity. This review provides a brief insight to all these mechanisms and tries to deduce the possible reasons of remission of type 2 diabetes after bariatric surgery.

Entities:  

Keywords:  Bariatric surgery; Morbid obesity; Type 2 diabetes

Year:  2015        PMID: 26090370      PMCID: PMC4468896          DOI: 10.12998/wjcc.v3.i6.504

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  45 in total

1.  Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids.

Authors:  J Stadler; H S Stern; K S Yeung; V McGuire; R Furrer; N Marcon; W R Bruce
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

2.  Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.

Authors:  Nam Q Nguyen; Tamara L Debreceni; Jenna E Bambrick; Bridgette Chia; Judith Wishart; Adam M Deane; Chris K Rayner; Michael Horowitz; Richard L Young
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

3.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

4.  Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study.

Authors:  Joan F Carroll; Susan F Franks; Adam B Smith; David R Phelps
Journal:  Obes Surg       Date:  2008-07-29       Impact factor: 4.129

Review 5.  Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.

Authors:  Michael M Swarbrick; Peter J Havel
Journal:  Metab Syndr Relat Disord       Date:  2008-06       Impact factor: 1.894

6.  GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.

Authors:  Amanda Jiménez; Roser Casamitjana; Lílliam Flores; Salvadora Delgado; Antonio Lacy; Josep Vidal
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

7.  The gut hormones in appetite regulation.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  J Obes       Date:  2011-09-22

8.  Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus.

Authors:  Michael Cobble
Journal:  Diabetol Metab Syndr       Date:  2012-03-05       Impact factor: 3.320

Review 9.  Mechanism linking diabetes mellitus and obesity.

Authors:  Abdullah S Al-Goblan; Mohammed A Al-Alfi; Muhammad Z Khan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-12-04       Impact factor: 3.168

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.